Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Magnus

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Journal of Virology|November 21, 2008
Estimating the stoichiometry of human immunodeficiency virus entryCarsten Magnus, Peter Rusert, Sebastian Bonhoeffer, et al.
Journal of Immunological Methods|September 18, 2013
Mathematical models: a key to understanding HIV envelope interactions?Carsten Magnus, Oliver F Brandenberg, Peter Rusert, et al.
Plos Pathogens|January 9, 2015
Different infectivity of HIV-1 strains is linked to number of envelope trimers required for entryOliver F Brandenberg, Carsten Magnus, Peter Rusert, et al.
Plos One|March 6, 2023
A machine learning approach to support triaging of primary versus secondary headache patients using complete blood countFei Yang, Tong Meng, Ben Torben-Nielsen, et al.
Plos Pathogens|July 10, 2015
Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-DependentLucia Reh, Carsten Magnus, Merle Schanz, et al.
Plos Pathogens|May 5, 2017
Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parametersOliver F Brandenberg, Carsten Magnus, Peter Rusert, et al.
Clinical Pharmacology and Therapeutics|December 24, 2024
The Open Hand Initiative: Facilitating the Use of Real-World Evidence in Regulatory Submissions Through Collaboration and TransparencyElodie Baumfeld Andre, Matthew Gee, Carsten Magnus, et al.
Retrovirology|October 8, 2014
Partial rescue of V1V2 mutant infectivity by HIV-1 cell-cell transmission supports the domain's exceptional capacity for sequence variationOliver F Brandenberg, Peter Rusert, Carsten Magnus, et al.
Plos Pathogens|January 26, 2018
Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineageLucia Reh, Carsten Magnus, Claus Kadelka, et al.
The Journal of Experimental Medicine|June 8, 2011
Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodiesPeter Rusert, Anders Krarup, Carsten Magnus, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Journal of Virology|November 21, 2008
Estimating the stoichiometry of human immunodeficiency virus entryCarsten Magnus, Peter Rusert, Sebastian Bonhoeffer, et al.
Journal of Immunological Methods|September 18, 2013
Mathematical models: a key to understanding HIV envelope interactions?Carsten Magnus, Oliver F Brandenberg, Peter Rusert, et al.
Plos Pathogens|January 9, 2015
Different infectivity of HIV-1 strains is linked to number of envelope trimers required for entryOliver F Brandenberg, Carsten Magnus, Peter Rusert, et al.
Plos One|March 6, 2023
A machine learning approach to support triaging of primary versus secondary headache patients using complete blood countFei Yang, Tong Meng, Ben Torben-Nielsen, et al.
Plos Pathogens|July 10, 2015
Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-DependentLucia Reh, Carsten Magnus, Merle Schanz, et al.
Plos Pathogens|May 5, 2017
Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parametersOliver F Brandenberg, Carsten Magnus, Peter Rusert, et al.
Clinical Pharmacology and Therapeutics|December 24, 2024
The Open Hand Initiative: Facilitating the Use of Real-World Evidence in Regulatory Submissions Through Collaboration and TransparencyElodie Baumfeld Andre, Matthew Gee, Carsten Magnus, et al.
Retrovirology|October 8, 2014
Partial rescue of V1V2 mutant infectivity by HIV-1 cell-cell transmission supports the domain's exceptional capacity for sequence variationOliver F Brandenberg, Peter Rusert, Carsten Magnus, et al.
Plos Pathogens|January 26, 2018
Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineageLucia Reh, Carsten Magnus, Claus Kadelka, et al.
The Journal of Experimental Medicine|June 8, 2011
Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodiesPeter Rusert, Anders Krarup, Carsten Magnus, et al.
Pageof 3